Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Lantmännen in conjunction with acquisition from Tate&Lyle
Mandate

Vinge advises Lantmännen in conjunction with acquisition from Tate&Lyle

March 28, 2019 M&A

Vinge has advised Lantmännen in connection with its acquisition of British Tate&Lyle’s Swedish oat production operations.

The acquisition is a part of Lantmännen’s continued focus on additional processing of oats to, inter alia, the food manufacturing industry.

Vinge’s team consisted of partner Christina Kokko together with, among others, associates Karl Klackenberg and David Lundahl (M&A), partner Johan Cederblad and associate Hampus Olsson (Environmental/Permits) as well as associates Hedvig Ekdahl (Commerical Agreements), Lisa Ullman (Employment), Karolina Cohrs (Real Property) and Klara Secher (IP).
 

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024